What Petwealth does

Petwealth (legally Petwell Inc. d/b/a Petwealth) is a Miami-based, Delaware-incorporated pet health diagnostics company founded in April 2025 and emerging from stealth in April 2026. The company sells at-home PCR diagnostic test kits for dogs and cats — a flagship Petwealth Pack priced at $249 combining fecal, oral, and respiratory panels that screen for 100+ pathogens, and individual single-organ panels priced at $125. Samples are processed in Petwealth's own CLIA-certified molecular laboratory with a 24–48 hour turnaround, after which customers receive a digital report with plain-language insights and a built-in 24/7 veterinary telehealth link through Pawp. A proprietary algorithmic layer, the Petwealth Health Score™, aggregates 50+ biomarker data points into a numerical index intended for proactive, pre-symptomatic monitoring of companion-animal health.

Name

Petwealth

Legal name

Petwell Inc.

Website

https://petwealth.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Direct-to-Consumer Diagnostic Kit Sales: One-time hardware/kit sales via the Petwealth e-commerce storefront, with The Petwealth Pack (canine or feline) priced at $249 and individual fecal/oral/respiratory panels priced at $125 each, processed in Stripe checkout.
2. Subscription Plans: Certain services are available on a subscription basis with auto-renewal at the end of each billing period; subscribers can cancel any time through account settings. Specific subscription tiers and prices are not publicly disclosed.
3. Veterinary and Partner Pricing: Special pricing is available for veterinarians and B2B partners (e.g., daycares, breeders, shelters, pharmacy groups, biotech/research, and Kennel Connection facility clients) via a dedicated 'For Partners' page; exact partner rates are not publicly disclosed.
4. B2B Channel Partnership Revenue (Kennel Connection): Exclusive diagnostic partnership with Kennel Connection integrating Petwealth's fecal, oral, and respiratory panels into Kennel Connection's platform serving 5,500+ U.S. pet care facilities, creating a new revenue stream for participating facilities.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels8 records

Core offering

Petwealth sells at-home PCR diagnostic test kits for dogs and cats, including individual fecal/oral/respiratory panels ($125 each) and comprehensive Petwealth Packs ($249) that combine all three panels into a single kit. Samples are collected at home via simple swab and shipped to the company's CLIA-certified molecular laboratory, where gold-standard PCR diagnostics screen 100+ pathogens with results delivered in 24-48 hours via a digital report. The offering includes a proprietary Petwealth Health Score™ that summarizes 50+ biomarker data points into a plain-language index, plus built-in 24/7 veterinary telehealth access through Pawp.

Product overview

Petwealth is a platform-plus-modules architecture built around at-home PCR pet health diagnostics for dogs and cats. The product line is anchored by two flagship comprehensive Collection Packs — the Canine Petwealth Pack ($249) and the Feline Petwealth Pack ($249) — each combining three single-organ test panels: Fecal Health Panel ($125), Respiratory Health Panel ($125), and Oral Health Panel ($125), available separately as standalone kits for each species. All kits are processed by Petwealth's CLIA-certified molecular laboratory and return AI-powered results in 24–48 hours. Layered on top of the diagnostic kits are the proprietary Petwealth Health Score™ (an algorithmic biomarker-summary product built from 50+ data points) and two access surfaces — the Pet Parent Dashboard and the Veterinary Professional Dashboard. Distribution and clinical-grade reach are extended through technical integrations with Kennel Connection (embedded across 5,500+ pet care facilities) and Pawp (24/7 veterinary telehealth built into every report).

Differentiator

Problem solved

Functional benefit

Brands

• The Petwealth Pack: Comprehensive at-home PCR diagnostic testing kit available for both Canine and Feline, combining fecal, oral, and respiratory sample collection into one kit.
• Petwealth Health Score™

Products and services

• Petwealth Pack (Canine Collection) Flagship at-home PCR diagnostic kit for dogs priced at $249. Combines the Canine Fecal, Respiratory, and Oral Health Panels into a single kit screening 100+ pathogens with lab-verified results delivered digitally in 24-48 hours. Designed for individual pet parents seeking proactive health screening for their dogs.
• Petwealth Pack (Feline Collection) Flagship at-home PCR diagnostic kit for cats priced at $249. Combines the Feline Fecal, Respiratory, and Oral Health Panels into a single kit screening 100+ pathogens with lab-verified results delivered digitally in 24-48 hours. Designed for individual cat owners and multi-cat homes.
• Canine Fecal Health Panel Standalone at-home PCR fecal test for dogs priced at $125. Screens 30-40 gut-health and pathogen markers for parasites, bacterial imbalances, and gut-related stress, with results delivered in 24-48 hours.
• Canine Respiratory Health Panel Standalone at-home PCR respiratory test for dogs priced at $125. Screens 30-40 viral and bacterial respiratory pathogens responsible for coughs, airway infections, and kennel cough, with results delivered in 24-48 hours.
• Canine Oral Health Panel Standalone at-home PCR oral test for dogs priced at $125. Screens 30-40 harmful oral bacteria and gum-related markers linked to gum disease, periodontal infections, and chronic bad breath, with results delivered in 24-48 hours.
• Feline Fecal Health Panel Standalone at-home PCR fecal test for cats priced at $125. Screens parasites, harmful bacteria, and gut imbalances in felines; designed for multi-cat homes and detecting subtle litter-box changes, with results delivered in 24-48 hours.
• Feline Respiratory Health Panel Standalone at-home PCR respiratory test for cats priced at $125. Screens viral and bacterial pathogens causing sneezing, nasal discharge, watery eyes, and upper respiratory infections in felines, with results delivered in 24-48 hours.
• Feline Oral Health Panel Standalone at-home PCR oral test for cats priced at $125. Screens harmful oral bacteria and gum-related markers linked to dental disease, gum inflammation, and chronic bad breath in felines, with results delivered in 24-48 hours.

Quantifiable outcome

• 99.9% stated PCR pathogen detection sensitivity, versus traditional methods that 'catch problems late'.
• +5 more outcomes

Named customers4 records

Segments7 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability6 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered flagship / core strategic partnership, core embedded partner, parent-level relationship (via kennel connection) and emerging / pipeline.

• Kennel Connection (a 100GROUP company)flagship / core strategic partnershipTechnology or Integration · 22 April 2026Exclusive diagnostic partnership announced on April 22, 2026, integrating Petwealth's clinical-grade PCR fecal, oral, and respiratory health panels (AI-powered results in 24–48 hours) directly into the Kennel Connection software platform. Kennel Connection serves over 5,500 U.S. pet care locations (daycares, boarding facilities, hotels, groomers), giving Petwealth exclusive access to the pet care management software channel as its exclusive diagnostic partner.
• Pawpcore embedded partnerTechnology or Integration · 7 April 2026Telehealth integration announced April 7, 2026 alongside Petwealth's emergence from stealth. Every Petwealth report includes built-in 24/7 access to Pawp's licensed veterinarians, no appointment needed. Pawp operates independently of Petwealth and is referenced in Terms of Service as a third-party veterinary telehealth provider whose services are governed by Pawp's own terms and policies.
• 100GROUPparent-level relationship (via kennel connection)Strategic or Co-development Partner100GROUP is described as the parent company of Kennel Connection, making it the indirect counterparty for the exclusive diagnostic partnership that anchors Petwealth's B2B distribution into 5,500+ U.S. pet care facilities.
• Biotech & Research Institutions (ecosystem segment)emerging / pipelineStrategic or Co-development PartnerPetwealth offers a data partnership opportunity grounded in real-world companion animal diagnostics; its PCR platform generates structured, high-fidelity health data at scale for biotech companies and research institutions seeking clinical insights and resistance profiling.
• Pharma & Therapeutics Companies (ecosystem segment)emerging / pipelineStrategic or Co-development PartnerPetwealth offers a clinical insights pipeline for pharmaceutical and therapeutic companies that maps diagnostic findings to treatment pathways, from pathogen identification to resistance profiling and product relevance.
• Pharmacy Groups (ecosystem segment)emerging / pipelineGTM or Marketing PartnerPetwealth works with pharmacy groups to extend pet lives via at-home diagnostics from its CLIA-certified lab, providing faster diagnostics and access to prescriptions for pet parents.
• Shelters & Rescues (ecosystem segment)emerging / pipelineGTM or Marketing PartnerPetwealth is building subsidized testing programs for rescue organizations that prioritize prevention, helping shelters screen animals before adoption and give new families confidence in pet health from day one.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Basepaws: Cat-focused at-home DNA and health testing brand, now part of Petcare Inc./Zoetis. Comparable species-specialized DTC diagnostic kit model for feline pet parents, with overlapping positioning on early detection and preventive care.
• MySimplePetLab: Direct-to-consumer at-home pet health testing kits including fecal, urine, and tick-borne disease panels. Closest direct peer on the DTC at-home multi-panel pet diagnostic model, competing for the same proactive pet parent with sub-$200 kits.
• Embark Veterinary: Direct-to-consumer pet genetic and health testing company for dogs, offering at-home swab-based test kits. Comparable to Petwealth in DTC channel, pet-parent target customer, and at-home diagnostic kit model, though focused on DNA rather than pathogen PCR.
• 5Strands: Direct-to-consumer at-home pet intolerance and health testing kits using hair/fur samples. Comparable DTC at-home pet diagnostic motion with similar target customer (concerned pet parent) and similar price-point kit SKU strategy.
• Wisdom Panel (Wisdom Health): Direct-to-consumer pet DNA and health screening brand owned by Mars Petcare. Comparable DTC at-home testing motion targeting pet parents with breed and health insights; competes for the same share of pet-parent testing wallet.

Broad incumbents

• Antech Diagnostics (Mars Petcare): Major U.S. veterinary reference laboratory network owned by Mars Petcare, serving the majority of U.S. veterinary clinics with comprehensive diagnostic panels. Closest direct comparable on lab-based PCR diagnostics for vet channel, but operates only through veterinary clinics rather than DTC.
• Zoetis Diagnostics: Animal health diagnostics arm of global animal pharma leader Zoetis, offering Vetscan in-clinic analyzers and reference lab services. Comparable PCR/rapid-test technology for companion animal pathogens and shared veterinary channel focus.
• IDEXX Laboratories: Largest U.S. veterinary diagnostics company operating reference labs and in-clinic analyzers (Catalyst Dx, ProCyte Dx, Snapshot Dx) used by tens of thousands of vet clinics. Comparable clinical-grade diagnostic technology stack (PCR/chemistry/imaging) and target veterinary end-customer, but at vastly greater scale and via B2B-only.

Emerging players

• PetDx: Veterinary molecular diagnostics company whose flagship OncoK9 liquid biopsy test uses next-generation sequencing for canine cancer detection. Comparable emerging molecular-diagnostics-for-pets positioning and CLIA-grade lab infrastructure, but specialized in oncology rather than infectious disease.

Others

• Pawp: Direct-to-consumer 24/7 veterinary telehealth subscription service and Petwealth's embedded telehealth partner. Comparable target customer (proactive pet parent), complementary rather than competing offering, and partner rather than competitor in Petwealth's funnel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Petwealth